A 3-Year Follow-Up of Pre-Emptive vs Deferred Treatment of Cytomegalovirus Disease in Renal Transplantation., Mark A. Schnitzler, Troy G. Metheney, Jose F. Rueda, Robert Woodward, Jeffrey A. Lowell, Gary G. Singer, Surendra Shenoy, Todd K. Howard, Gregory A. Storch, Daniel C. Brennan
Health Management & Policy

Symptomatic cytomegalovirus infection in renal transplant recipients given either Minnesota antilymphoblast globulin (MALG) or OKT3 for rejection prophylaxis., Thomas C. Bailey, William G. Powderly, Gregory A. Storch, Stephen B. Miller, John D. Dunkel, Robert Woodward, Edward Spitznagel, Douglas W. Hanto, Wm. Claiborne Dunagan
Health Management & Policy